AU Patent

AU6239798A — Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs

Assigned to Bristol Myers Squibb Co · Expires 1998-08-07 · 28y expired

What this patent protects

Patent listed against lomitapide-mesylate.

Drugs covered by this patent

lomitapide-mesylate (LOMITAPIDE MESYLATE)

Patent Metadata

Patent number: AU6239798A
Jurisdiction: AU
Classification: —
Expires: 1998-08-07
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.